These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36890610)

  • 21. Genomic organization and expression of a human gene for Myc-associated zinc finger protein (MAZ).
    Song J; Murakami H; Tsutsui H; Tang X; Matsumura M; Itakura K; Kanazawa I; Sun K; Yokoyama KK
    J Biol Chem; 1998 Aug; 273(32):20603-14. PubMed ID: 9685418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PRCC, the commonest TFE3 fusion partner in papillary renal carcinoma is associated with pre-mRNA splicing factors.
    Skalsky YM; Ajuh PM; Parker C; Lamond AI; Goodwin G; Cooper CS
    Oncogene; 2001 Jan; 20(2):178-87. PubMed ID: 11313942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MGA, L3MBTL2 and E2F6 determine genomic binding of the non-canonical Polycomb repressive complex PRC1.6.
    Stielow B; Finkernagel F; Stiewe T; Nist A; Suske G
    PLoS Genet; 2018 Jan; 14(1):e1007193. PubMed ID: 29381691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelin axis expression is markedly different in the two main subtypes of renal cell carcinoma.
    Douglas ML; Richardson MM; Nicol DL
    Cancer; 2004 May; 100(10):2118-24. PubMed ID: 15139053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PCGF6 controls neuroectoderm specification of human pluripotent stem cells by activating SOX2 expression.
    Lan X; Ding S; Zhang T; Yi Y; Li C; Jin W; Chen J; Liang K; Wang H; Jiang W
    Nat Commun; 2022 Aug; 13(1):4601. PubMed ID: 35933409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PCGF6 regulates stem cell pluripotency as a transcription activator via super-enhancer dependent chromatin interactions.
    Huang X; Wei C; Li F; Jia L; Zeng P; Li J; Tan J; Sun T; Jiang S; Wang J; Tang X; Zhao Q; Liu B; Rong L; Li C; Ding J
    Protein Cell; 2019 Oct; 10(10):709-725. PubMed ID: 31041782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myc-Associated Zinc Finger Protein Promotes Metastasis of Papillary Thyroid Cancer.
    Zheng C; Wu H; Zhang S; Tian R; Long H; Zhang H; Guo X; Li D; Tan S; Zhu X
    Front Biosci (Landmark Ed); 2023 Aug; 28(8):162. PubMed ID: 37664917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptional regulation by zinc-finger proteins Sp1 and MAZ involves interactions with the same cis-elements.
    Song J; Ugai H; Nakata-Tsutsui H; Kishikawa S; Suzuki E; Murata T; Yokoyama KK
    Int J Mol Med; 2003 May; 11(5):547-53. PubMed ID: 12684688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polycomb group ring finger protein 6 suppresses Myc-induced lymphomagenesis.
    Tanaskovic N; Dalsass M; Filipuzzi M; Ceccotti G; Verrecchia A; Nicoli P; Doni M; Olivero D; Pasini D; Koseki H; Sabò A; Bisso A; Amati B
    Life Sci Alliance; 2022 Aug; 5(8):. PubMed ID: 35422437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of Myc-associated zinc finger protein with DCC, the product of a tumor-suppressor gene, during the neural differentiation of P19 EC cells.
    Ugai H; Li HO; Komatsu M; Tsutsui H; Song J; Shiga T; Fearon E; Murata T; Yokoyama KK
    Biochem Biophys Res Commun; 2001 Sep; 286(5):1087-97. PubMed ID: 11527412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. G-quadruplexes promote the motility in MAZ phase-separated condensates to activate CCND1 expression and contribute to hepatocarcinogenesis.
    Wang W; Li D; Xu Q; Cheng J; Yu Z; Li G; Qiao S; Pan J; Wang H; Shi J; Zheng T; Sui G
    Nat Commun; 2024 Feb; 15(1):1045. PubMed ID: 38316778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Roles of Myc-associated zinc finger protein in malignant tumors.
    Zheng C; Wu H; Jin S; Li D; Tan S; Zhu X
    Asia Pac J Clin Oncol; 2022 Dec; 18(6):506-514. PubMed ID: 35098656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination.
    Bossone SA; Asselin C; Patel AJ; Marcu KB
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7452-6. PubMed ID: 1502157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Protective Role for Androgen Receptor in Clear Cell Renal Cell Carcinoma Based on Mining TCGA Data.
    Zhao H; Leppert JT; Peehl DM
    PLoS One; 2016; 11(1):e0146505. PubMed ID: 26814892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-34c regulates the permeability of blood-tumor barrier via MAZ-mediated expression changes of ZO-1, occludin, and claudin-5.
    Zhao L; Wang P; Liu Y; Ma J; Xue Y
    J Cell Physiol; 2015 Mar; 230(3):716-31. PubMed ID: 25201524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 16p11.2 transcription factor
    Haller M; Au J; O'Neill M; Lamb DJ
    Proc Natl Acad Sci U S A; 2018 Feb; 115(8):E1849-E1858. PubMed ID: 29432158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FGFR2 overexpression predicts survival outcome in patients with metastatic papillary renal cell carcinoma.
    Tsimafeyeu I; Khasanova A; Stepanova E; Gordiev M; Khochenkov D; Naumova A; Varlamov I; Snegovoy A; Demidov L
    Clin Transl Oncol; 2017 Feb; 19(2):265-268. PubMed ID: 27379982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of the transcription factor MAZ as a regulator of erythropoiesis.
    Deen D; Butter F; Daniels DE; Ferrer-Vicens I; Ferguson DCJ; Holland ML; Samara V; Sloane-Stanley JA; Ayyub H; Mann M; Frayne J; Garrick D; Vernimmen D
    Blood Adv; 2021 Aug; 5(15):3002-3015. PubMed ID: 34351390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease.
    Wagener N; Edelmann D; Benner A; Zigeuner R; Borgmann H; Wolff I; Krabbe LM; Musquera M; Dell'Oglio P; Capitanio U; Klatte T; Cindolo L; May M; Brookman-May SD;
    PLoS One; 2017; 12(9):e0184173. PubMed ID: 28934212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MAZ induces MYB expression during the exit from quiescence via the E2F site in the MYB promoter.
    Álvaro-Blanco J; Urso K; Chiodo Y; Martín-Cortázar C; Kourani O; Arco PG; Rodríguez-Martínez M; Calonge E; Alcamí J; Redondo JM; Iglesias T; Campanero MR
    Nucleic Acids Res; 2017 Sep; 45(17):9960-9975. PubMed ID: 28973440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.